Compare MDLN & BDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MDLN | BDX |
|---|---|---|
| Founded | 1966 | 1897 |
| Country | United States | United States |
| Employees | 45000 | N/A |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.4B | 43.0B |
| IPO Year | N/A | 1997 |
| Metric | MDLN | BDX |
|---|---|---|
| Price | $42.97 | $157.06 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 23 | 13 |
| Target Price | $50.48 | ★ $186.00 |
| AVG Volume (30 Days) | ★ 9.7M | 2.4M |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 2.89% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.25 |
| Revenue | N/A | ★ $21,840,000,000.00 |
| Revenue This Year | $10.88 | N/A |
| Revenue Next Year | $7.69 | $3.02 |
| P/E Ratio | $658.75 | ★ $622.00 |
| Revenue Growth | N/A | ★ 8.24 |
| 52 Week Low | $32.82 | $140.11 |
| 52 Week High | $50.88 | $213.08 |
| Indicator | MDLN | BDX |
|---|---|---|
| Relative Strength Index (RSI) | 68.59 | 60.47 |
| Support Level | $40.90 | $153.27 |
| Resistance Level | $44.11 | $159.79 |
| Average True Range (ATR) | 1.49 | 3.94 |
| MACD | 0.91 | 1.20 |
| Stochastic Oscillator | 92.33 | 88.16 |
Medline is the largest medical-surgical products and supply chain solutions provider in the US. The company generates over 90% of its revenue domestically and serves some of the largest US health systems. Medline offers approximately 190,000 Medline-branded products across more than 250 product families—including front line care, surgical solutions, and laboratory and diagnostics—as well as roughly 150,000 third-party products sourced from over 1,250 vendors. The company maintains prime vendor relationships with many customers, acting as the primary consolidated logistics partner for their medical-surgical needs. Medline has significant scale, supported by more than 30 manufacturing facilities and a fleet of over 2,000 owned delivery trucks. Medline went public in December 2025.
Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.